These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 33180378

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
    Ogura I, Kobayashi E, Nakahara K, Igarashi K, Haga-Tsujimura M, Toshima H.
    Ann Nucl Med; 2019 Oct; 33(10):776-782. PubMed ID: 31342316
    [Abstract] [Full Text] [Related]

  • 4. Comparison of maximum and mean standardized uptake values of jaw pathologies with bone SPECT/CT: an especial focus on medication-related osteonecrosis of the jaw.
    Minami Y, Ogura I.
    Nucl Med Commun; 2022 Dec 01; 43(12):1188-1194. PubMed ID: 36345763
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Maximum standardized uptake value of normal structures in the head and neck with bone SPECT/CT.
    Tezuka Y, Ogura I.
    J Med Imaging Radiat Oncol; 2022 Oct 01; 66(7):936-939. PubMed ID: 34989162
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Maximum and mean standardized uptake values of medication-related osteonecrosis of the jaw with bone SPECT/CT: comparison of mandibular pathologies, control and temporomandibular joints.
    Tezuka Y, Ogura I.
    Dentomaxillofac Radiol; 2023 Sep 01; 52(6):20230119. PubMed ID: 37395742
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.
    Moridera K, Kitajima K, Yoshikawa K, Takaoka K, Tsuchitani T, Noguchi K, Kishimoto H, Yamakado K.
    Jpn J Radiol; 2022 May 01; 40(5):492-499. PubMed ID: 34851501
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Volumetric analysis of mandibular lesions with SPECT/CT: a pilot clinical study of maximum standardized uptake value.
    Minami Y, Ogawa R, Ogura I.
    Pol J Radiol; 2022 May 01; 87():e311-e315. PubMed ID: 35892069
    [Abstract] [Full Text] [Related]

  • 20. Tc-99m hydroxymethylene diphosphonate scintigraphy, computed tomography, and magnetic resonance imaging of osteonecrosis in the mandible: Osteoradionecrosis versus medication-related osteonecrosis of the jaw.
    Ogura I, Sasaki Y, Sue M, Oda T, Kameta A, Hayama K.
    Imaging Sci Dent; 2019 Mar 01; 49(1):53-58. PubMed ID: 30941288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.